Today's amended 8-K gives us the information needed to calculate what 2020 Q4 looked like. Revenue ramped very nicely during that quarter and gross margin remained over 91%. 550 nebulizers were sold during this quarter, compared to 300 in the previous 6 months of revenue generation.